AMAR REMEDIES | MARICO | AMAR REMEDIES/ MARICO |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -0.5 | 47.2 | - | View Chart |
P/BV | x | 0.1 | 17.8 | 0.3% | View Chart |
Dividend Yield | % | 0.0 | 1.0 | - |
![]() ![]() |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
AMAR REMEDIES Jun-12 |
MARICO Mar-20 |
AMAR REMEDIES/ MARICO |
5-Yr Chart Click to enlarge
|
||
High | Rs | 164 | 404 | 40.6% | |
Low | Rs | 86 | 234 | 36.8% | |
Sales per share (Unadj.) | Rs | 261.6 | 56.7 | 461.7% | |
Earnings per share (Unadj.) | Rs | 17.4 | 8.1 | 215.3% | |
Cash flow per share (Unadj.) | Rs | 22.3 | 9.2 | 243.2% | |
Dividends per share (Unadj.) | Rs | 0 | 4.00 | 0.0% | |
Dividend yield (eoy) | % | 0 | 1.3 | 0.0% | |
Book value per share (Unadj.) | Rs | 100.7 | 23.5 | 429.3% | |
Shares outstanding (eoy) | m | 26.16 | 1,290.90 | 2.0% | |
Bonus/Rights/Conversions | - | - | - | ||
Price / Sales ratio | x | 0.5 | 5.6 | 8.5% | |
Avg P/E ratio | x | 7.2 | 39.5 | 18.2% | |
P/CF ratio (eoy) | x | 5.6 | 34.8 | 16.1% | |
Price / Book Value ratio | x | 1.2 | 13.6 | 9.1% | |
Dividend payout | % | 0 | 49.5 | 0.0% | |
Avg Mkt Cap | Rs m | 3,270 | 411,474 | 0.8% | |
No. of employees | `000 | NA | 1.7 | 0.0% | |
Total wages/salary | Rs m | 163 | 4,780 | 3.4% | |
Avg. sales/employee | Rs Th | NM | 43,438.2 | - | |
Avg. wages/employee | Rs Th | NM | 2,838.5 | - | |
Avg. net profit/employee | Rs Th | NM | 6,193.6 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 6,844 | 73,150 | 9.4% | |
Other income | Rs m | 21 | 1,240 | 1.7% | |
Total revenues | Rs m | 6,865 | 74,390 | 9.2% | |
Gross profit | Rs m | 1,131 | 14,690 | 7.7% | |
Depreciation | Rs m | 128 | 1,400 | 9.1% | |
Interest | Rs m | 398 | 500 | 79.6% | |
Profit before tax | Rs m | 626 | 14,030 | 4.5% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | -50 | -290 | 17.2% | |
Tax | Rs m | 121 | 3,310 | 3.7% | |
Profit after tax | Rs m | 455 | 10,430 | 4.4% | |
Gross profit margin | % | 16.5 | 20.1 | 82.3% | |
Effective tax rate | % | 19.3 | 23.6 | 81.9% | |
Net profit margin | % | 6.6 | 14.3 | 46.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 4,904 | 31,820 | 15.4% | |
Current liabilities | Rs m | 3,581 | 17,850 | 20.1% | |
Net working cap to sales | % | 19.3 | 19.1 | 101.2% | |
Current ratio | x | 1.4 | 1.8 | 76.8% | |
Inventory Days | Days | 124 | 69 | 180.5% | |
Debtors Days | Days | 100 | 27 | 372.4% | |
Net fixed assets | Rs m | 1,689 | 8,580 | 19.7% | |
Share capital | Rs m | 262 | 1,291 | 20.3% | |
"Free" reserves | Rs m | 2,358 | 29,000 | 8.1% | |
Net worth | Rs m | 2,635 | 30,291 | 8.7% | |
Long term debt | Rs m | 507 | 100 | 507.0% | |
Total assets | Rs m | 6,862 | 50,020 | 13.7% | |
Interest coverage | x | 2.6 | 29.1 | 8.9% | |
Debt to equity ratio | x | 0.2 | 0 | 5,828.3% | |
Sales to assets ratio | x | 1.0 | 1.5 | 68.2% | |
Return on assets | % | 12.4 | 21.9 | 56.9% | |
Return on equity | % | 17.3 | 34.4 | 50.1% | |
Return on capital | % | 31.0 | 46.9 | 66.2% | |
Exports to sales | % | 4.0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 273 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 273 | 3,830 | 7.1% | |
Fx outflow | Rs m | 2 | 1,534 | 0.1% | |
Net fx | Rs m | 271 | 2,295 | 11.8% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -313 | 12,180 | -2.6% | |
From Investments | Rs m | -489 | -440 | 111.0% | |
From Financial Activity | Rs m | 769 | -11,460 | -6.7% | |
Net Cashflow | Rs m | -33 | 450 | -7.2% |
Indian Promoters | % | 25.5 | 59.6 | 42.8% | |
Foreign collaborators | % | 0.0 | 0.1 | - | |
Indian inst/Mut Fund | % | 9.2 | 2.6 | 353.8% | |
FIIs | % | 0.0 | 31.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 65.3 | 6.7 | 974.6% | |
Shareholders | 13,061 | 37,128 | 35.2% | ||
Pledged promoter(s) holding | % | 99.7 | 0.0 | - |
Compare AMAR REMEDIES With: JYOTHY LABS HUL BAJAJ CONSUMER CARE GODREJ INDUSTRIES COLGATE
Compare AMAR REMEDIES With: P&G (US) UNILEVER PLC. (UK) HYPERMARCAS (Brazil)
Nifty and Sensex ended the week gaining 0.60% and 0.52% respectively. Bulls started the week roaring but since Wednesday, the momentum seemed to be tiring.
Here's an analysis of the annual report of MARICO for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of MARICO. Also includes updates on the valuation of MARICO.
For the quarter ended September 2020, MARICO has posted a net profit of Rs 3 bn (up 8.3% YoY). Sales on the other hand came in at Rs 20 bn (up 8.7% YoY). Read on for a complete analysis of MARICO's quarterly results.
For the quarter ended June 2020, MARICO has posted a net profit of Rs 4 bn (up 23.8% YoY). Sales on the other hand came in at Rs 19 bn (down 11.1% YoY). Read on for a complete analysis of MARICO's quarterly results.
For the quarter ended March 2020, MARICO has posted a net profit of Rs 2 bn (down 50.7% YoY). Sales on the other hand came in at Rs 15 bn (down 7.0% YoY). Read on for a complete analysis of MARICO's quarterly results.
For the quarter ended December 2019, MARICO has posted a net profit of Rs 3 bn (up 9.7% YoY). Sales on the other hand came in at Rs 18 bn (down 2.0% YoY). Read on for a complete analysis of MARICO's quarterly results.
More Views on NewsMy new guide will show you the huge potential in future proof businesses.
The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.
The charts are telling the bulls to be cautious.
Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...
Ajit Dayal on the investing strategy for 2021 and beyond.
More